Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Xilio Therapeutics (NASDAQ:XLO) through any online brokerage.
Other companies in Xilio Therapeutics’s space includes: Galecto Inc (NASDAQ:GLTO), Kezar Life Sciences Inc (NASDAQ:KZR), ABVC BioPharma Inc (NASDAQ:ABVC), Fortress Biotech Inc (NASDAQ:FBIOP) and INmune Bio Inc (NASDAQ:INMB).
Xilio Therapeutics has a consensus price target of $5.75.
The stock price for Xilio Therapeutics (NASDAQ: XLO) is $0.648 last updated January 23, 2026 at 4:40 PM EST.
There are no upcoming dividends for Xilio Therapeutics.
Xilio Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Xilio Therapeutics.
Xilio Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.